naftopidil has been researched along with 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Awaji, T; Hirasawa, A; Ikegaki, I; Shibata, K; Takada, T; Take, H; Tsujimoto, G | 1 |
| Asano, T; Ikegaki, I; Shibata, K; Takei, R; Tsujimoto, G | 1 |
2 other study(ies) available for naftopidil and 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone
| Article | Year |
|---|---|
Vascular alpha1-adrenoceptor subtype selectivity and alpha1-blocker-induced orthostatic hypotension.
Topics: Adrenergic alpha-Antagonists; Animals; Base Sequence; CHO Cells; Cricetinae; DNA Primers; Hypotension, Orthostatic; Iodine Radioisotopes; Male; Naphthalenes; Phenethylamines; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Recombinant Proteins; RNA, Messenger; Tetralones | 1998 |
Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; Binding, Competitive; Blood Pressure; CHO Cells; Cricetinae; Dogs; Humans; Male; Naphthalenes; Phenethylamines; Phenylephrine; Piperazines; Pressure; Prostate; Radioligand Assay; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Tetralones | 1999 |